BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17325347)

  • 1. Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins.
    Rosas CT; König P; Beer M; Dubovi EJ; Tischer BK; Osterrieder N
    J Gen Virol; 2007 Mar; 88(Pt 3):748-757. PubMed ID: 17325347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
    Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
    Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of a replicon particle vaccine expressing the E2 glycoprotein of bovine viral diarrhea virus (BVDV) in cattle.
    Loy JD; Gander J; Mogler M; Vander Veen R; Ridpath J; Harris DH; Kamrud K
    Virol J; 2013 Jan; 10():35. PubMed ID: 23356714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic Cell Targeting of Bovine Viral Diarrhea Virus E2 Protein Expressed by
    Wang Y; Feng B; Niu C; Jia S; Sun C; Wang Z; Jiang Y; Cui W; Wang L; Xu Y
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31242608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and immunogenicity of the recombinant Lactobacillus acidophilus pMG36e-E0-LA-5 of bovine viral diarrhea virus.
    Zhao Y; Jiang L; Liu T; Wang M; Cao W; Bao Y; Qin J
    J Virol Methods; 2015 Dec; 225():70-5. PubMed ID: 26386184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant E2 glycoprotein of bovine viral diarrhea virus induces a solid humoral neutralizing immune response but fails to confer total protection in cattle.
    Chimeno Zoth S; Leunda MR; Odeón A; Taboga O
    Braz J Med Biol Res; 2007 Jun; 40(6):813-8. PubMed ID: 17581680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves.
    R El-Attar LM; Thomas C; Luke J; A Williams J; Brownlie J
    Vaccine; 2015 Jul; 33(32):4004-12. PubMed ID: 26079613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
    Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
    Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
    Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A
    Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
    Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
    Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity evaluation of recombinant Lactobacillus casei W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant.
    Jia S; Huang X; Li H; Zheng D; Wang L; Qiao X; Jiang Y; Cui W; Tang L; Li Y; Xu Y
    Microb Cell Fact; 2020 Oct; 19(1):186. PubMed ID: 33004035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
    Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
    Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge.
    Liang R; van den Hurk JV; Landi A; Lawman Z; Deregt D; Townsend H; Babiuk LA; van Drunen Littel-van den Hurk S
    J Gen Virol; 2008 Feb; 89(Pt 2):453-466. PubMed ID: 18198376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
    Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
    Williams LBA; Fry LM; Herndon DR; Franceschi V; Schneider DA; Donofrio G; Knowles DP
    PLoS One; 2019; 14(4):e0215605. PubMed ID: 31002724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
    Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
    PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of long-term antibody responses to two inactivated bovine viral diarrhoea virus (BVDV) vaccines.
    González AM; Arnaiz I; Yus E; Eiras C; Sanjuán M; Diéguez FJ
    Vet J; 2014 Mar; 199(3):424-8. PubMed ID: 24461201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune response and assessment of vaccine virus shedding in calves receiving modified live virus vaccines containing bovine herpesvirus-1 and bovine viral diarrhoea virus 1a.
    Fulton RW; Saliki JT; Burge LJ; Payton ME
    J Vet Med B Infect Dis Vet Public Health; 2003 Feb; 50(1):31-7. PubMed ID: 12710498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunologic responses of vaccinated and unvaccinated calves to infection with a virulent type-II isolate of bovine viral diarrhea virus.
    Cortese VS; West KH; Hassard LE; Carman S; Ellis JA
    J Am Vet Med Assoc; 1998 Nov; 213(9):1312-9. PubMed ID: 9810390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenge with Bovine viral diarrhea virus by exposure to persistently infected calves: protection by vaccination and negative results of antigen testing in nonvaccinated acutely infected calves.
    Fulton RW; Johnson BJ; Briggs RE; Ridpath JF; Saliki JT; Confer AW; Burge LJ; Step DL; Walker DA; Payton ME
    Can J Vet Res; 2006 Apr; 70(2):121-7. PubMed ID: 16639944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.